Menu
Back to User profile » Dr Mohammad Al-Sanea
Papers published by Dr Mohammad Al-Sanea:
Cytotoxic Potential, Metabolic Profiling, and Liposomes of Coscinoderma sp. Crude Extract Supported by in silico Analysis
Musa A, Elmaidomy AH, Sayed AM, Alzarea SI, Al-Sanea MM, Mostafa EM, Hendawy OM, Abdelgawad MA, Youssif KA, Refaat H, Alaaeldin E, Abdelmohsen UR
International Journal of Nanomedicine 2021, 16:3861-3874
Published Date: 4 June 2021
Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights
Abdelgawad MA, Musa A, Almalki AH, Alzarea SI, Mostafa EM, Hegazy MM, Mostafa-Hedeab G, Ghoneim MM, Parambi DGT, Bakr RB, Al-Muaikel NS, Alanazi AS, Alharbi M, Ahmad W, Bukhari SNA, Al-Sanea MM
Drug Design, Development and Therapy 2021, 15:2325-2337
Published Date: 31 May 2021
Molecular Characterization of Hepatitis C Virus for Developed Antiviral Agents Resistance Mutations and New Insights into in-silico Prediction Studies
El-Sokkary MMA, Gotina L, Al-Sanea MM, Pae AN, Elbargisy RM
Infection and Drug Resistance 2020, 13:4235-4248
Published Date: 23 November 2020
Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety
Al-Sanea MM, Gotina L, Mohamed MFA, Grace Thomas Parambi D, Gomaa HAM, Mathew B, Youssif BGM, Alharbi KS, Elsayed ZM, Abdelgawad MA, Eldehna WM
Drug Design, Development and Therapy 2020, 14:497-508
Published Date: 4 February 2020